- Home
- GRCE vs FCUV Comparison
GRCE vs FCUV Comparison
Compare GRCE & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- FCUV
- Stock Information
- Founded
- GRCE 2002
- FCUV 2012
- Country
- GRCE United States
- FCUV United States
- Employees
- GRCE N/A
- FCUV 46
- Industry
- GRCE
- FCUV Industrial Machinery/Components
- Sector
- GRCE
- FCUV Industrials
- Exchange
- GRCE NYSE
- FCUV Nasdaq
- Market Cap
- GRCE 32.1M
- FCUV 26.5M
- IPO Year
- GRCE N/A
- FCUV N/A
- Fundamental
- Price
- GRCE $2.13
- FCUV $3.40
- Analyst Decision
- GRCE Strong Buy
- FCUV
- Analyst Count
- GRCE 1
- FCUV 0
- Target Price
- GRCE $12.00
- FCUV N/A
- AVG Volume (30 Days)
- GRCE 27.2K
- FCUV 13.1K
- Earning Date
- GRCE 05-15-2025
- FCUV 05-14-2025
- Dividend Yield
- GRCE N/A
- FCUV N/A
- EPS Growth
- GRCE N/A
- FCUV N/A
- EPS
- GRCE N/A
- FCUV N/A
- Revenue
- GRCE N/A
- FCUV $398,137.00
- Revenue This Year
- GRCE N/A
- FCUV N/A
- Revenue Next Year
- GRCE N/A
- FCUV N/A
- P/E Ratio
- GRCE N/A
- FCUV N/A
- Revenue Growth
- GRCE N/A
- FCUV N/A
- 52 Week Low
- GRCE $2.07
- FCUV $1.50
- 52 Week High
- GRCE $4.97
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- FCUV 35.28
- Support Level
- GRCE N/A
- FCUV $4.45
- Resistance Level
- GRCE N/A
- FCUV $4.42
- Average True Range (ATR)
- GRCE 0.00
- FCUV 0.36
- MACD
- GRCE 0.00
- FCUV -0.12
- Stochastic Oscillator
- GRCE 0.00
- FCUV 0.00
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.